AILERON THERAPEUTICS INC (ALRN) Forecast, Price Target & Analyst Ratings

NASDAQ:ALRN • US00887A2042

Current stock price

2.11 USD
+0.18 (+9.33%)
At close:
2.11 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AILERON THERAPEUTICS INC (ALRN).

Forecast Snapshot

Consensus Price Target

Price Target
$13.26
+ 528.44% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2024
EPS Estimate
-$0.49
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$13.26
Upside
+ 528.44%
From current price of $2.11 to mean target of $13.26, Based on 8 analyst forecasts
Low
$7.07
Median
$13.26
High
$19.95

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for ALRN. The average price target is 13.26 USD. This implies a price increase of 528.44% is expected in the next year compared to the current price of 2.11.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALRN Current Analyst RatingALRN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

ALRN Historical Analyst RatingsALRN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
ALRN was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ALRN.
In the previous month the buy percentage consensus was at a similar level.
ALRN was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-04-18Ladenburg ThalmannMaintains Buy -> Buy
2023-12-01Ladenburg ThalmannUpgrade Neutral -> Buy
2022-06-30HC Wainwright & Co.Maintains Buy
2022-06-29William BlairDowngrade Outperform -> Market Perform

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2024
EPS Estimate
-$0.49
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
68.21%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-118.18%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
ALRN revenue by date.ALRN revenue by date.
N/AN/AN/AN/A
EBITDA
YoY % growth
ALRN ebitda by date.ALRN ebitda by date.
-12.56M-17.94M
-42.83%		-22.88M
-27.54%		-31.68M
-38.46%		-29.8M
5.93%		-20.34M
31.74%		-26.49M
-30.24%		-27.48M
-3.74%		-15.229M
44.58%		N/AN/AN/AN/A
EBIT
YoY % growth
ALRN ebit by date.ALRN ebit by date.
-12.89M-18.17M
-40.96%		-23.01M
-26.64%		-31.9M
-38.64%		-29.96M
6.08%		-20.5M
31.58%		-26.61M
-29.80%		-27.65M
-3.91%		-15.348M
44.49%		N/A
-99.08%		N/A
-20.55%		N/A
-84.22%		N/A
-25.32%
Operating Margin
ALRN operating margin by date.ALRN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ALRN eps by date.ALRN eps by date.
N/AN/AN/A-41.20
15.10%		-25.80
37.38%		-12.60
51.16%		-5.80
53.97%		-6.02
-3.79%		N/A
65.91%		N/A
-11.33%		N/A
16.16%		N/A
5.22%		N/A
1.12%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 24
EPS
Q2Q % growth		-0.49
68.21%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-7.943M
-8.78%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALRN Yearly EPS VS EstimatesALRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30 -40

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
3.70%
EPS Next 5 Year
2.99%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AILERON THERAPEUTICS INC / ALRN Forecast FAQ

What do analysts expect the price target to be for AILERON THERAPEUTICS INC (ALRN)?

8 analysts have analysed ALRN and the average price target is 13.26 USD. This implies a price increase of 528.44% is expected in the next year compared to the current price of 2.11.

What are the consensus estimates for AILERON THERAPEUTICS INC (ALRN) next earnings?

The consensus EPS estimate for the next earnings of AILERON THERAPEUTICS INC (ALRN) is -0.49 USD and the consensus revenue estimate is 0 USD.

How many analysts cover AILERON THERAPEUTICS INC (ALRN) stock?

The number of analysts covering AILERON THERAPEUTICS INC (ALRN) is 8.